The National Pharmacy Association reports fake obesity cases, and the GPhC regulator says pharmacists who fail to verify weight will face sanctions.
Recap by typeshit. Full story at Seoul Economic Daily.
The Washington Post looks at why so many users report shedding, a problem now nicknamed "Ozempic hair," and what new research suggests about the cause.
She says GLP-1 drugs slow how fast the stomach empties. That can let stomach contents reach the lungs during sedation, even after fasting.
The endocrinologist cautions that an interesting effect seen in animals does not mean a compound is suitable for human use.
The account calls the up to 28% weight loss impressive but says only about half of participants finished, citing nausea, constipation and skin sensitivity.
Dr. Mouhib Naddour says thymosin beta-4 shows promise only in lab and animal studies, and no unapproved peptide is cleared to treat lung disease.
By week 80, up to half of participants were down to mild apnea. Lead author Ron Grunstein credits weight loss, not a direct effect on breathing.
Loading…